Table 2 Baseline scores (T0), twelve months scores (T1) and mean change scores with standard deviations.
From: Responsiveness of the EQ-5D in breast cancer patients in their first year after treatment
| Â | EORTC QLQ-C30 global health | EQ VAS | EQ 5D Index | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Subgroup | T0 | T1 | Δ (sd) | T0 | T1 | Δ (sd) | SRM | T0 | T1 | Δ (sd) | SRM |
Moderate-large deterioration (n = 23) | 79.3 | 56.9 | -22.5 (10.8) | 73.0 | 59.8 | -13.2 (11.2) | -1.17 | 0.72 | 0.57 | -0.15 (0.29) | -0.52 |
Small deterioration (n = 14) | 75.6 | 67.3 | -8.3 (0.0) | 74.4 | 69.4 | -5.1 (12.0) | -0.42 | 0.73 | 0.72 | -0.01 (0.18) | -0.05 |
No change (n = 55) | 80.9 | 80.9 | 0.0 (0.0) | 79.0 | 79.9 | 0.7 (8.8) | 0.08 | 0.82 | 0.82 | 0.00 (0.21) | 0.01 |
Small improvement (n = 28) | 71.2 | 80.1 | 8.3 (0.0) | 70.9 | 77.7 | 6.1 (7.7) | 0.79 | 0.78 | 0.80 | 0.02 (0.14) | 0.16 |
Moderate-large improvement (n = 72) | 58.2 | 85.6 | 27.4 (11.9) | 65.0 | 77.4 | 12.1 (12.7) | 0.95 | 0.71 | 0.83 | 0.13 (0.20) | 0.62 |